Welcome to our dedicated page for Greenpro Cap SEC filings (Ticker: GRNQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Greenpro Capital Corp. (NASDAQ: GRNQ) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Greenpro Capital is a Nevada corporation headquartered in Kuala Lumpur, Malaysia, and describes itself as a business incubator with a diversified portfolio across finance, technology, banking, Green-X for STOs, and health and wellness.
For GRNQ, Form 8-K current reports are particularly important. Recent 8-K filings describe subscription agreements for private placements of common stock conducted under exemptions from registration provided by Section 4(a)(2) of the Securities Act and Regulation D and/or Regulation S. These filings specify the number of shares issued, purchase prices, and state that proceeds are planned for operating capital. Other 8-Ks detail acquisition agreements, such as the agreement to acquire a minority interest in Greenophene Technologies Limited in exchange for restricted shares of Greenpro common stock.
Greenpro has also filed 8-K reports regarding changes in its independent registered public accounting firm, documenting the resignation of a prior auditor, the engagement of SFAI Malaysia PLT, and the absence of reportable disagreements as defined in SEC rules. These disclosures help investors understand the company’s audit oversight and financial reporting environment.
Through Stock Titan, users can review GRNQ’s SEC filings as they appear on EDGAR, including current reports and other documents that may be filed over time. The platform’s AI-powered summaries are designed to highlight key terms in Greenpro’s filings—such as unregistered sales of equity securities, material definitive agreements, auditor changes, and acquisition terms—so readers can quickly grasp the significance of each document without reading the full legal text.
Investors researching GRNQ can use this page to track how Greenpro Capital raises capital, structures acquisitions, manages auditor relationships, and complies with U.S. disclosure requirements, all based on the company’s own filed documents.
Greenpro Capital Corp. completed a share exchange, issuing 8,500,000 shares of common stock to Forekast Limited shareholders for a 13.6% minority stake in Forekast as of March 31, 2026. The company received 1,360 Forekast ordinary shares and did not obtain control of Forekast.
This equity issuance increased Greenpro’s common shares outstanding from 8,625,813 on March 30, 2026 to 17,125,813 on the closing date, significantly diluting existing holders. New large shareholders include BHL Ltd. with 3,250,000 shares (18.98% of outstanding) and several other entities each holding 1,125,000 shares (6.57% each).
Greenpro Capital Corp. reports full-year 2025 results showing revenue of $2,073,557, down from $3,496,405 in 2024 as it continues focusing on advisory, consulting and venture activities across Asia. The company operates blockchain-based, Shariah-compliant security-token platform Green-X and maintains a broad network of corporate services and real-estate holding subsidiaries.
Greenpro’s venture portfolio has seen extensive write-downs, with multiple minority investments fully impaired in prior years and further small impairments in 2025, including the remaining $11,981 in Greenpro Trust and $92 in SEATech Ventures. In January 2025, it sold its fully impaired Jocom Holdings stake for $39,950, booking a $39,800 gain.
As of June 30, 2025, non-affiliate equity value was $7,592,303 at $1.57 per share, and 8,625,813 common shares were outstanding as of March 30, 2026. Post year-end, Greenpro agreed to issue 8,500,000 shares to acquire about 13.6% of Forekast Limited on a fully diluted basis, expanding its strategic investment portfolio.
Greenpro Capital Corp. furnished an information statement disclosing stockholder approval by written consent of a Share Exchange Agreement to acquire 1,360 ordinary shares of Forekast Limited (representing 13.6% of FKL) in exchange for 8,500,000 shares of Greenpro Common Stock.
The Board reported that the Majority Stockholders holding 4,463,908 shares (approximately 51.75%) executed the written consent. On a pro forma basis, Greenpro expects total shares outstanding of 17,125,813, with Exchange Share recipients holding 49.63% and existing shareholders holding 50.37%. The issuance will occur at closing, subject to closing conditions and Nasdaq listing approvals, and will be no earlier than twenty calendar days after mailing.
Greenpro Capital Corp. approved a Share Exchange under which the company will issue 8,500,000 shares of Common Stock in exchange for 1,360 Forekast Limited ordinary shares, representing approximately 49.63% of Greenpro's pro forma equity.
The Majority Stockholders, holding 4,463,908 shares (approximately 51.75%), executed written consent approving the transaction on February 9, 2026. Pro forma capitalization will be 17,125,813 shares outstanding after the issuance. The issuance exceeds 20% of pre-transaction outstanding shares, so the Company sought approval under Nasdaq Listing Rule 5635(a) and, to the extent applicable, 5635(d). The closing is subject to customary conditions and may not occur earlier than 20 calendar days after mailing this Information Statement.
Greenpro Capital Corp. plans a share exchange in which it will issue 8,500,000 new shares of common stock to the shareholders of Forekast Limited in return for 1,360 Forekast shares, equal to about 13.6% of Forekast’s equity. After closing, Exchange Share recipients are expected to own roughly 49.63% of Greenpro, with existing shareholders reduced to about 50.37%, resulting in substantial dilution. The board and holders of approximately 51.75% of Greenpro’s voting power have already approved the transaction by written consent. No shareholder vote or action is required, and no dissenters’ rights are available.
Greenpro Capital Corp. signed a Share Exchange Agreement to acquire a 13.6% fully diluted equity interest in Forekast Limited. In return, Greenpro will issue 8,500,000 shares of its common stock to Forekast’s shareholders at closing, subject to customary conditions and an outside closing date of March 31, 2026.
Greenpro Capital Corp. disclosed that it entered into a Subscription Agreement on December 18, 2025 for a private placement of 100,000 shares of its common stock at $1.50 per share, raising aggregate gross proceeds of $150,000. The transaction closed the same day and involves newly issued common stock with a par value of $0.0001 per share.
The company relied on exemptions from registration under Section 4(a)(2) of the Securities Act and Regulation D and/or Regulation S, with purchasers representing that they are accredited investors or non‑U.S. persons. No underwriters participated, and Greenpro Capital plans to use the proceeds for operating capital.
Greenpro Capital Corp. disclosed an agreement to acquire a 0.99% equity stake in Greenophene Technologies Limited from an individual seller. In return, Greenpro will issue 800,000 shares of its common stock, valuing the transaction at US$1,200,000, or US$1.50 per share.
The 800,000 shares will be issued as restricted securities under Rule 144 and are being offered in a private placement relying on Rule 506 of Regulation D. All of these shares will be held in escrow and remain under the Company’s control until the closing of the acquisition, which is subject to customary conditions, representations, warranties, and securities law compliance by both parties.
Greenpro Capital Corp. (GRNQ) reported a small private stock financing. On November 14, 2025, the company sold 150,000 shares of common stock at $1.30 per share in a private placement to accredited individual investors, generating $195,000 in gross proceeds. The transaction was completed under Regulation D and Section 4(a)(2) of the Securities Act, meaning the shares were issued without SEC registration. No underwriters were involved, and the company plans to use the cash raised for operating capital.
Greenpro Capital (GRNQ) filed its Q3 2025 10‑Q, reporting a wider loss on lower revenue and a going‑concern warning. Quarterly revenue was $393,228 versus $539,699 a year ago, with a net loss of $513,226 and EPS of $(0.07). For the nine months, revenue was $1,173,075 versus $1,559,272, and net loss was $1,722,930.
Cash and equivalents were $775,388 as of September 30, 2025, and operating cash outflow was $1,180,574 year‑to‑date. Deferred revenue rose to $683,873, reflecting payments received for services not yet completed. Total assets were $6.12M and liabilities $1.79M, with stockholders’ equity of $4.33M.
The company disclosed “substantial doubt” about its ability to continue as a going concern. In June, it issued 700,000 shares in private placements for $760,000. Digital assets were $236,165 at fair value as of September 30, 2025. As of November 13, 2025, 8,375,813 common shares were outstanding.